Clinical Trial Update: Ingenol Mebutate Gel, 0.015% Repeat Use for Multiple Actinic Keratoses on Face and Scalp [Phase 3]

View source ↗

Summary

Phase 3 trial update for repeat use of ingenol mebutate gel 0.015% for actinic keratoses on the face and scalp. Results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Actinic Keratosis

Drugs mentioned

• Ingenol Mebutate Gel, 0.015% (ingenol mebutate)

Snippet

Sponsor: LEO Pharma | Conditions: Actinic Keratosis | Phase 3 | Status: COMPLETED | Results posted: 2016-05-09